SCHEMBL9912709

SCHEMBL9912709

Fc1ccc(SC(Sc2ccc(F)cc2)Sc2ccc(F)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SERPINH1 P50454 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
ACHE P22303 1/20 0.36
ATM Q13315 1/20 0.36
PTPN1 P18031 1/20 0.35
CDC25A P30304 1/20 0.35
CDC25B P30305 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1368088 0.83 MEN1 (0.40) NPC1HTTRAB9ASMN1; SMN2GAA
SCHEMBL8744335 0.81 GAA (0.39) NPC1HTTRAB9ASMN1; SMN2GAA
SCHEMBL5110593 0.74 GAA (0.53) NPC1HTTRAB9ASMN1; SMN2GAA
SCHEMBL2751920 0.74 GAA (0.39) NPC1HTTRAB9ASMN1; SMN2GAA
SCHEMBL8325281 0.72 MAOA (0.39) NPC1HTTRAB9ASMN1; SMN2GAA
SCHEMBL28808736 0.72 MEN1 (0.38) NPC1HTTRAB9ASMN1; SMN2GAA
SCHEMBL223757 0.71 FBP1 (0.52) SMN1; SMN2MEN1KMT2ACA1CA2
SCHEMBL576260 0.71 MEN1 (0.48) HTTMEN1KMT2ACYP1A2CYP2C9
SCHEMBL28622779 0.69 MEN1 (0.46) NPC1HTTRAB9ASMN1; SMN2GAA
SCHEMBL6420122 0.69 ALDH1A1 (0.44) NPC1HTTRAB9ASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9055743-B2 Alpha, beta-unsaturated imines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-06-16 US disclosed
US-9055743-B2 Alpha, beta-unsaturated imines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-06-16 US disclosed
US-20130310254-A1 Alpha, beta-unsaturated imines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-11-21 US disclosed
WO-2012072489-A1 ALPHA,BETA-UNSATURATED IMINES BAYER CROPSCIENCE AG (DE) 2012-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130310254-A1 Alpha, beta-unsaturated imines TTPA, ECH1, GSTO1 NPC1 615/4885HTT 3691/4885RAB9A 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.